Bold Insight and The Office of Experience partner to deliver outstanding user experiences.
Back to team page
Yvette Granger
Managing Partner
Yvette’s background is in human factors engineering and human-system integration (HSI) research. She has designed methodologies, defined project scope, planned research activities, and supervised programs of research as well as individual research projects involving medical devices, touch screen interfaces, websites, and enterprise applications. In her most recent role, Yvette managed the Human Factors research programs for multi-million-dollar client accounts within the healthcare sector. She is a member of HFES, AAMI, and the Epsilon Mu Eta honor society. Yvette has an MS in Engineering Management with a certificate in HSI from the University of Missouri.
Bold facts
Learn more about
Something unique about you summed up in one sentence
Your favorite part of working at Bold Insight
In your spare time (or if you had spare time), you would absolutely do this:
How long have you been in the UX field?
You cannot start the day without doing this...
Your favorite city in the world is...and why?
Your ultimate celebrity dinner party guest list would include:
Long-term personal or professional goal?
Read our team’s latest bold insights
When designing an experience, are you really thinking about the customer first?
While every organization has constraints to consider when designing experiences for customers or users, designing the ideal customer experience is completely possible within those constraints. Begin by identifying the experience you want your customer to have and work “backward” from there.
UX project logistics: choosing the right vendors for project success
Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.